Energy metabolism homeostasis in cardiovascular diseases

Lu-Yun Wang1, Chen Chen1

  • 1Division of Cardiology, Tongji Hospital, Tongji Medical College and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiologic Disorders, Huazhong University of Science and Technology, Wuhan, China.

Insights

Cardiovascular disease (CVD) involves energy metabolism disturbances. Understanding heart metabolism, including lipid and glucose pathways, is key to developing new CVD treatments and cardiac regeneration strategies.

Area of Science:

  • Cardiovascular Science
  • Metabolic Biology
  • Cardiac Physiology

Background:

  • Cardiovascular disease (CVD) is a primary cause of death globally.
  • Disturbances in energy metabolism are early indicators in various CVDs, including coronary heart disease, diabetic cardiomyopathy, and heart failure.
  • Understanding myocardial metabolism is crucial for elucidating CVD pathophysiology.

Purpose of the Study:

  • To explore the role of myocardial energy homeostasis disturbance in cardiovascular diseases.
  • To summarize lipid and glucose metabolism in the heart.
  • To investigate metabolic regulation in neonatal and aging hearts and propose mechanisms for cardiac regeneration and degeneration.

Main Methods:

  • Literature review and synthesis of current research on cardiac metabolism.
  • Analysis of metabolic regulation during different life stages (neonatal, aging).
  • Overview of molecular networks linking cardiac proliferation, regeneration, and metabolic dysfunction.

Main Results:

  • Lipid metabolism/lipotoxicity and glucose metabolism/insulin resistance are key aspects of cardiac energy homeostasis.
  • Metabolic regulation differs significantly between neonatal and aging hearts.
  • Emerging molecular networks highlight the interplay between cardiac proliferation, regeneration, and metabolic disturbances.

Conclusions:

  • Myocardial energy metabolism plays a critical role in the development and progression of cardiovascular diseases.
  • Novel therapeutic targets for CVDs may arise from understanding cardiac metabolic regulation and regeneration pathways.
  • Further research into the molecular networks governing cardiac metabolism holds promise for a new era in CVD treatment.

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
843
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.9K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Introduction to Metabolism01:30

Introduction to Metabolism

Metabolism encompasses all biochemical reactions in a living organism, facilitating both the breakdown and synthesis of biomolecules. These metabolic processes are categorized into catabolic and anabolic pathways, which operate in a coordinated manner to ensure energy balance and cellular function.Catabolic Pathways and Energy ReleaseCatabolic pathways involve the breakdown of complex macromolecules such as carbohydrates, lipids, and proteins into smaller structures like monosaccharides, fatty...
562
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K